Phillips Joseph A, Lopez-Colon Dalia, Zhu Zhi, Xu Ye, Tan Weihong
Center for Research at the Bio/Nano Interface, Department of Chemistry, Shands Cancer Center, University of Florida Genetics Institute, and McKnight Brain Institute, University of Florida, Gainesville, FL 32611-7200, USA.
Anal Chim Acta. 2008 Jul 28;621(2):101-8. doi: 10.1016/j.aca.2008.05.031. Epub 2008 May 21.
Identifying cells associated with specific disease states is critically important for the early detection and diagnosis of cancer. To facilitate this task, molecular probes, which bind biomarkers that are either specifically or differentially expressed in diseased cells relative to healthy cells, provide a simple and effective method. This review focuses on the use of DNA aptamers as molecular probes for cancer cells. These aptamers are created by means of the cell-based Systematic Evolution of Ligands by EXponential enrichment (SELEX) process, which uses whole disease cells as targets. We describe at length the steps of the cell-SELEX process and discuss several applications for the aptamers, including profiling leukemia patient samples and discovering cell-surface cancer biomarkers. We conclude with a discussion of an aptamer-conjugated nanoparticle enrichment and detection scheme.
识别与特定疾病状态相关的细胞对于癌症的早期检测和诊断至关重要。为了便于完成这项任务,分子探针提供了一种简单有效的方法,它能结合相对于健康细胞在病变细胞中特异性或差异性表达的生物标志物。本综述重点关注DNA适配体作为癌细胞分子探针的应用。这些适配体是通过基于细胞的指数富集配体系统进化(SELEX)过程产生的,该过程以整个病变细胞为靶点。我们详细描述了细胞SELEX过程的步骤,并讨论了适配体的几种应用,包括分析白血病患者样本和发现细胞表面癌症生物标志物。最后,我们讨论了一种适配体偶联纳米颗粒富集和检测方案。